Fetuin A in Hashimoto Thyroiditis

Hashimoto Thyroiditis Clinical Trial

Official title: Fetuin A as a New Marker of Inflammation in Hashimoto Thyroiditis

Status Completed

Clinical Trial Summary

Fetuin-A levels are reported to be low as a negative acute phase reactant in systemical inflammatory situations. Hashimoto thyroiditis is characterized with inflammation. In this study, we hypothesised that the serum fetuin A levels could be found to be low due to inflammation in patients with Hashimoto thyroiditis

Clinical Trial Description

Patients ≥ 20 years of age being followed up at the outpatient clinics of the Internal Medicine Department in Medeniyet University Goztepe Training and Research Hospital and fulfilling the eligibility criteria will be included in the study. Approval of the local ethics committee and informed consent of the participants will be received for the study. The study is conducted in accordance with the Declaration of Helsinki. Demographic characteristics, concomitant diseases, smoking and alcohol drinking habits, concomitant medication usage, anthropometric and biochemistry data of the eligible patients will be recorded. Patient group will consist of patients with newly diagnosed Hashimoto thyroiditis and the control group will consist of healthy volunteers.

Groups will be compared according to their demographic, an¬thropometric and biochemistry data and serum fetuin-A levels. In order to detect the relationship between the serum fetuin-A levels and clinical features, correlation analyses will be done. ;

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Hashimoto Disease
• Hashimoto Thyroiditis
• Thyroiditis

• NCT number: NCT01884649
• Study type: Observational [Patient Registry]
• Source: Istanbul Medeniyet University
• Status: Completed
• Phase: N/A
• Start date: May 2012
• Completion date: October 2012